LENZ Therapeutics LENZ
NASDAQ LENZ
$3.84 -0.02 (-0.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Capital Expenditures (2020 - 2026)

Updated

LENZ Therapeutics (LENZ) recorded Capital Expenditures of $16,000 in Q2 2026, down 93.3% from $240,000 a year earlier and down 11.1% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Capital Expenditures (2020 - 2026) Analysis & Trends

On a TTM basis, LENZ Therapeutics' Capital Expenditures came in at $511,000 as of Jun 30, 2026, down 25.4% year-over-year; for FY2025, it came in at $827,000, up 76.7% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $468,000 in FY2024, $30,000 in FY2023 (-99.5%), $6.59 million in FY2022 (+14.9%) and $5.74 million in FY2021 (+271.5%).
  • The Q2 2026 figure is the lowest quarterly Capital Expenditures since Q1 2023.
  • On a year-over-year basis, Capital Expenditures has declined for three consecutive quarters, with an average decline of 7.0% over the last five quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 809.2% in Q1 2022, against a decline of 99.8% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $18,000 (Q1 2026), $38,000 (Q4 2025) and $439,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 LENZ Therapeutics 121.27 Mn 121.27 Mn 5.21 Mn 16,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16,000.00
Mar 31, 2026 18,000.00
Dec 31, 2025 38,000.00
Sep 30, 2025 439,000.00
Jun 30, 2025 240,000.00
Mar 31, 2025 110,000.00
Dec 31, 2024 149,000.00
Sep 30, 2024 186,000.00
Jun 30, 2024 133,000.00
Jun 30, 2023 24,000.00
Mar 31, 2023 6,000.00
Dec 31, 2022 1.02 Mn
Sep 30, 2022 915,000.00
Jun 30, 2022 1.39 Mn
Mar 31, 2022 3.27 Mn
Dec 31, 2021 981,000.00
Sep 30, 2021 3.64 Mn
Jun 30, 2021 763,000.00
Mar 31, 2021 360,000.00
Dec 31, 2020 612,000.00
API Access

LENZ Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LENZ&period=max&api_key=YOUR_API_KEY